Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mélanie Héroult
Rogaratinib: A Potent and Selective Pan-FGFR Inhibitor With Broad Antitumor Activity in FGFR-overexpressing Preclinical Cancer Models
International Journal of Cancer
Cancer Research
Oncology
Heparin Affin Regulatory Peptide Binds to Vascular Endothelial Growth Factor (VEGF) and Inhibits VEGF-induced Angiogenesis
Oncogene
Cancer Research
Genetics
Molecular Biology
Related publications
TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Discovery of Potent Irreversible Pan-Fibroblast Growth Factor Receptor (FGFR) Inhibitors
Bcl‐2 Inhibitors Enhance FGFR Inhibitor‐induced Mitochondrial‐dependent Cell Death in FGFR 2 Mutant Endometrial Cancer
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
A Phase I, Multicenter, Dose-Escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients With Advanced Solid Tumors Harboring FGFR Gene Alterations
Clinical Cancer Research
Cancer Research
Oncology
TAS4464, a Highly Potent and Selective Inhibitor of NEDD8 Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
GSK1070916, a Potent Aurora B/C Kinase Inhibitor With Broad Antitumor Activity in Tissue Culture Cells and Human Tumor Xenograft Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Targeting FGFR Signaling in Cancer
Clinical Cancer Research
Cancer Research
Oncology
In Vitro and in Vivo Evaluation of the Radiosensitizing Effect of a Selective FGFR Inhibitor (JNJ-42756493) for Rectal Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Antitumor Activity of the Selective Pan-Raf Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
Cancer Research
Cancer Research
Oncology
